“The two agreements are independent from each other and have similar terms including no exclusivity. Under the agreements the only fee payable by Cellmid to either of the consultants will be a success fee on completion of the sale or partnering of the midkine asset portfolio. The reason for signing two agreements is to fully exploit both partnering and divestment options efficiently. “
No consulting fee to be paid unless a deal is complete. Selling this asset or partnering now is a good thing imo as I can’t see cdy developing this further from here on as it would require substantial amount of funds
and time.
- Forums
- ASX - By Stock
- AN1
- Ann: CDY Engages Advisers to Facilitate Divestment from Lyramid
Ann: CDY Engages Advisers to Facilitate Divestment from Lyramid, page-8
Featured News
Add AN1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.690M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
AN1 (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online